0.6300
+0.0300
+(5.00%)
At close: January 24 at 11:32:44 AM EST
Breakdown
12/31/2023
12/31/2022
12/31/2021
Total Assets
2,170.0000
2,794.0000
2,836.0000
Total Liabilities Net Minority Interest
1,981.0000
698.0000
1,659.0000
Total Equity Gross Minority Interest
189.0000
2,096.0000
1,177.0000
Total Capitalization
189.0000
2,096.0000
1,177.0000
Common Stock Equity
189.0000
2,096.0000
1,177.0000
Capital Lease Obligations
20.0000
44.0000
--
Net Tangible Assets
189.0000
2,096.0000
1,177.0000
Working Capital
74.0000
2,089.0000
1,205.0000
Invested Capital
189.0000
2,096.0000
2,220.0000
Tangible Book Value
189.0000
2,096.0000
1,177.0000
Total Debt
20.0000
44.0000
1,043.0000
Share Issued
48,249.7070
42,855.1580
42,855.1580
Ordinary Shares Number
48,249.7070
42,855.1580
42,855.1580
12/31/2021 - 9/13/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
DRUG.CN Bright Minds Biosciences Inc.
46.47
+0.69%
BIOV.CN BioVaxys Technology Corp.
0.0600
0.00%
ENBI.CN Entheon Biomedical Corp.
0.4000
+29.03%
VM4.BE Vanda Pharmaceuticals Inc
4.2000
-0.94%
1GDA.F Zevra Therapeutics, Inc.
7.65
-1.29%
MBIO.CN MindBio Therapeutics Corp.
0.0250
0.00%
ORN.F Oryzon Genomics S.A.
1.4100
-3.16%
BT3.BE Lineage Cell Therapeutics Inc
0.5850
-7.87%
HQ1.MU Oruka Therapeutics Inc. R
12.20
0.00%
2Q5.BE Enochian BioSciences Inc
0.8480
-12.94%